Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
——
Mannkind logo
MannkindMNKD
——
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——
Arcus Biosciences logo
Arcus BiosciencesRCUS
——

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.55B+128%
Enterprise value$4.37B+139%
P/E62.3×—
P/S6×+1.9×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments?
Kiniksa Pharmaceuticals International, plc (KNSA) reported accrued progress collections and price adjustments of $31.81M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments changed year-over-year?
Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments decreased by 0.0% year-over-year, from $31.81M to $31.81M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments?
Over 3 years (2022 to 2025), Kiniksa Pharmaceuticals International, plc's accrued progress collections and price adjustments has grown at a 38.4% compound annual growth rate (CAGR), from $12M to $31.81M.